ctrl K

Price Alert

Caladrius Biosciences Inc... (CLBS)

NASDAQ: CLBS · Real-Time Price · USD

0.43

-0.08 (-16.05%)

At close: Sep 15, 2022, 6:00 AM

Caladrius Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	n/a	n/a	125.59M	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	125.59M	n/a	n/a	n/a
Operating Income	-6.63M	-6.71M	-6.79M	-6.93M	-7.19M	-8.06M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-6.63M	-6.71M	-6.79M	-6.93M	-7.19M	-8.06M
Net Income	-6.63M	-4.23M	-6.79M	-6.93M	-5.68M	-8.06M
Selling & General & Admin	3.48M	3.34M	2.7M	2.84M	2.82M	3.01M
Research & Development	3.24M	3.28M	4.15M	4.13M	4.33M	5.08M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	6.72M	6.62M	6.85M	6.97M	7.15M	8.09M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	6.72M	6.62M	6.85M	6.97M	7.15M	8.09M
Income Tax Expense	n/a	-2.48M	1.51M	n/a	-1.51M	n/a
Shares Outstanding (Basic)	60.53M	60.56M	59.61M	59.61M	59.51M	42.12M
Shares Outstanding (Diluted)	60.53M	60.56M	59.61M	59.61M	59.51M	42.12M
EPS (Basic)	-0.11	-0.07	-0.11	-0.12	-0.1	-0.19
EPS (Diluted)	-0.11	-0.07	-0.11	-0.12	-0.1	-0.19
EBITDA	-6.62M	-6.7M	-6.79M	-6.91M	-7.17M	-8.05M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	7K	7K	8K	14K	17K	16K